Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Land & Improvements (2017 - 2018)

Jaguar Health (JAGX) has disclosed Land & Improvements for 2 consecutive years, with $396247.0 as the latest value for Q1 2018.

  • On a quarterly basis, Land & Improvements changed N/A to $396247.0 in Q1 2018 year-over-year; TTM through Mar 2018 was $396247.0, a N/A change, with the full-year FY2017 number at $396247.0, changed N/A from a year prior.
  • Land & Improvements was $396247.0 for Q1 2018 at Jaguar Health, roughly flat from $396247.0 in the prior quarter.
  • In the past five years, Land & Improvements ranged from a high of $396247.0 in Q4 2017 to a low of $396247.0 in Q4 2017.